Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers

David L. Hayes, J. William Charboneau, B. D. Lewis, Samuel J. Asirvatham, Damian E. Dupuy, Nancy Y. Lexvold

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Clinicians who provide care for patients with implantable devices for rhythm management, ie, pacemakers and internal cardioverter defibrillators, must be aware of sources of interference that could affect device function. Intracardiac radiofrequency is a recognized source of potential interference. However, radiofrequency to extracardiac sites that are relatively close to the implanted device has not been investigated thoroughly. We present 2 patients with permanent pacemakers undergoing intrahepatic radiofrequency for the treatment of metastatic disease. No interference was documented in either patient. Additional in vitro and in vivo studies are needed to determine definite clinical guidelines for such patients.

Original languageEnglish (US)
Pages (from-to)950-952
Number of pages3
JournalMayo Clinic proceedings
Issue number9
StatePublished - 2001

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers'. Together they form a unique fingerprint.

Cite this